Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Management of Stable Ventricular Tachycardia in Pregnancy

Acute Management

  • The European Society of Cardiology recommends immediate electrical cardioversion for all sustained VT in pregnant patients, regardless of hemodynamic stability 1
  • Synchronized cardioversion is the definitive treatment for both stable and unstable sustained VT in pregnancy, with the same energy dosing as non-pregnant patients 1
  • The American Heart Association suggests applying electrode pads with the energy trajectory directed away from the uterus during cardioversion 2
  • Fetal monitoring should be performed during cardioversion (if time allows) and immediately post-cardioversion 2
  • Cardioversion has been reported safe at all stages of pregnancy 1, 2

Pharmacological Management

  • For sustained, hemodynamically stable, monomorphic VT, intravenous sotalol or procainamide are reasonable second-line options 1
  • Intravenous amiodarone should be considered only for VT that is refractory to electrical cardioversion or not responding to other drugs, despite its fetotoxic effects 1
  • The European Society of Cardiology guidelines prioritize immediate electrical cardioversion over pharmacological therapy as the primary approach, even in stable VT 1

Long-Term Management

  • For idiopathic sustained VT requiring chronic suppression, oral metoprolol, propranolol, or verapamil are first-line agents 1
  • Oral sotalol, flecainide, or propafenone should be considered if first-line agents fail 1
  • Beta-blockers should be used with caution in the first trimester 1
  • ICD implantation is recommended whenever clinically indicated during pregnancy, not delayed until after delivery 1

Special Considerations

  • Beta-blocking agents are mandatory during pregnancy and postpartum for patients with long QT syndrome, as they provide major benefit in preventing torsade de pointes 1
  • Atenolol should never be used for any arrhythmia in pregnancy due to risk of intrauterine growth retardation 1, 4
  • Amiodarone should be avoided unless all other options have failed, due to significant fetotoxic effects including thyroid dysfunction and growth restriction 1, 3
  • Class III drugs should not be used in cases with prolonged QTc 1
  • Catheter ablation may be considered for drug-refractory and poorly tolerated tachycardias during pregnancy 1, 3